Literature DB >> 14234788

REPLICATION OF A DEOXYRIBONUCLEIC ACID VIRUS IN THYMINE-DEFICIENT MAMMALIAN CELLS.

G A GENTRY, L A LAWSON, C C RANDALL.   

Abstract

Gentry, Glenn A. (University of Mississippi School of Medicine, Jackson), Lucy A. Lawson, and Charles C. Randall. Replication of a deoxyribonucleic acid virus in thymine-deficient mammalian cells. J. Bacteriol. 88:1324-1328. 1964.-Equine abortion virus (EAV), a deoxyribonucleic acid (DNA) virus, causes the degradation of host cell DNA to acid-soluble components in the L-M cell. It was hypothesized that inhibitors of DNA synthesis such as 5-fluorodeoxyuridine (FUdR) and amethopterin, which act by causing a deficiency in thymidine (TdR) nucleotides, would not block virus replication because the breakdown of the host cell DNA would supply sufficient TdR nucleotides for synthesis of viral DNA. The drugs were added 24 hr prior to the virus, amethopterin at 10(-6)m with adenosine included as a purine source, or FUdR at 10(-5)m. In either case, control experiments indicated that the thymineless state was achieved in the host cells. When EAV was added, neither FUdR nor amethopterin had any effect on the production of infectious virus, as determined by plaque assay, thus supporting the hypothesis.

Entities:  

Keywords:  DNA, VIRAL; EXPERIMENTAL LAB STUDY; FLUORODEOXYURIDINE; METHOTREXATE; PHARMACOLOGY; THYMINE; TISSUE CULTURE; VERTEBRATE VIRUSES; VIRUS CULTIVATION

Mesh:

Substances:

Year:  1964        PMID: 14234788      PMCID: PMC277411          DOI: 10.1128/jb.88.5.1324-1328.1964

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  10 in total

1.  MULTIPLICATION OF CANINE HEPATITIS VIRUS IN THE PRESENCE OF 5-FLUORODEOXYURIDINE.

Authors:  J E MOULTON; L M FRAZIER
Journal:  Proc Soc Exp Biol Med       Date:  1964-04

2.  STUDIES ON THE EFFECT OF 5-FLUORO-2'-DEOXYURIDINE ON POLYAMA T FORMATION IN MOUSE EMBRYO CELLS.

Authors:  R SHEININ
Journal:  Virology       Date:  1964-03       Impact factor: 3.616

3.  The nucleic acid content of equine abortion virus.

Authors:  R W DARLINGTON; C C RANDALL
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

4.  Equine herpes viruses.

Authors:  G PLUMMER; A P WATERSON
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

5.  Biochemical studies on adenovirus multiplication. III. Requirement for DNA synthesis.

Authors:  M GREEN
Journal:  Virology       Date:  1962-12       Impact factor: 3.616

6.  Effect of 5-halogenated pyrimidines on cell proliferation and adenovirus multiplication.

Authors:  L KJELLEN
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

7.  Adaptation of equine abortion virus to Earle's L cells in serum-free medium with plaque formation.

Authors:  C C RANDALL; L A LAWSON
Journal:  Proc Soc Exp Biol Med       Date:  1962-07

8.  DEGRADATION OF DEOXYRIBONUCLEIC ACID AND ALTERATION NUCLEIC ACID METABOLISM IN SUSPENSION CULTURES OF L-M CELLS INFECTED WITH EQUINE ABORTION VIRUS.

Authors:  C C RANDALL; B M WALKER
Journal:  J Bacteriol       Date:  1963-07       Impact factor: 3.490

9.  INCOMPLETE SIMIAN PAPOVAVIRUS SV40. FORMATION OF NON-INFECTIOUS VIRAL ANTIGEN IN THE PRESENCE OF FLUOROURACIL.

Authors:  J L MELNICK; S E STINEBAUGH; F RAPP
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

10.  Synthesis of virus-specific polymers in adenovirus-infected cells; effect of 5-fluorodeoxyuridine.

Authors:  J F FLANAGAN; H S GINSBERG
Journal:  J Exp Med       Date:  1962-08-01       Impact factor: 14.307

  10 in total
  2 in total

1.  Mycoplasmal deoxyribonuclease activity in virus-infected L-cell cultures.

Authors:  D A Stock; G A Gentry
Journal:  J Virol       Date:  1969-03       Impact factor: 5.103

2.  Kinetics of viral deoxyribonucleic acid, protein, and infectious particle production and alterations in host macromolecular syntheses in equine abortion (herpes) virus-infected cells.

Authors:  D J O'Callaghan; J M Hyde; G A Gentry; C C Randall
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.